Introduction
Freely accessible research publications support innovation in the public and private sectors by allowing previous research to be built upon, encouraging collaboration, speeding up research dissemination and improving the transparency of research across the world.
1-3 It also benefits public health by supporting informed decision-making. 4, 5 Open access means that readers do not have to pay to access peer-reviewed scientific research articles; however, open access is more ambitious than just making content free to read. 2 To realize the full potential of open access in supporting innovation, research publications should, on the condition that the source is appropriately attributed:
• be freely available to the end user at the time of publication
• allow for unrestricted reuse of content. 3 Creative Commons licences attached to publications allow authors to retain copyright of their work and to stipulate the restrictions that apply to its reuse. 6 A Creative Commons Attribution (CC BY) licence allows sharing and adaptation of published materials for commercial as well as non-commercial use. 6 It is recommended by the Open Access Scholarly Publishers Association as the least restrictive type of Creative Commons licence available and by the Budapest Open Access Initiative as the optimal licence for open access publishing. 7, 8 There is no harmonization between journals in their options for publishing open access and a key area of difference is the types of Creative Commons licence on offer: common derivatives of the CC BY licence include CC BY-NC, which restricts commercial reuse;
CC BY-ND, which restricts adaptation; and CC BY-NC-ND, which restricts both (Table S1 ). 9 Governmental and charitable research funders increasingly mandate publishing open access with a CC BY licence. [10] [11] [12] [13] The Medical Research Council, for example, requires grantees to publish their work in journals that offer immediate access with a CC BY licence. 10, 14 In 2014, the Charity Open Access Fund was established by six partner UK charities (Arthritis Research UK, Bloodwise, the British Heart Foundation, Cancer Research UK, Parkinson's UK and the Wellcome Trust) to ensure that the researchers and organizations they support can access the funds required to pay article processing charges and make research papers open access with a CC BY licence. 15 Although the pharmaceutical industry funds approximately half of all medical research, 16, 17 no pharmaceutical company currently mandates that the research they fund is published open access with a CC BY licence.
We set out to clarify the open access options offered by journals with high impact factors and whether pharmaceutical companies are given the same options as non-commercial funders.
Methods
Using We categorized the least restrictive open access variant offered by each journal, using our own classification, according to:
• whether a CC BY licence was offered
• whether there was an embargo period
• which version of the article would be available (published, accepted, submitted).
For journals that offered a CC BY licence, we also assessed:
• article processing charges
• funding requirements for obtaining a CC BY licence.
Between 6 December 2017 and 2 January 2018 we sent emails to the journals requesting confirmation of our findings (Table S2) .
Results

Least restrictive open access variant offered by journals
Fifty-three journals listed in the Journal Selector database had a 2015 impact factor of at least 15. Sixteen review journals were excluded and 37 journals from 14 publishers were included in this analysis. Immediate open access with a CC licence was offered by:
• 3 (30%) of the 10 journals with the highest impact factor (impact factor 30.4-137.6)
• 23 (62%) of the 37 journals analysed (Figures 1 and 2 ).
The types of CC licence available from these 23 journals were:
• CC BY from 23 journals (100%)
• CC BY-NC from 5 journals (22%)
• CC BY-NC-ND from 20 journals (87%).
The 14 journals, from six publishers, that did not offer open access with a CC licence offered access to different versions of the article either immediately, after a 6-month embargo period or after a 12-month embargo period (Table 2) . 
Category
The cost of open access with a CC BY licence
Of the 23 journals that offered a CC BY licence, 21 (91%) disclosed article processing charges on their websites. Across these journals, charges ranged from US$3000 to US$5000; the most common article processing charge (65% of journals) was US$5000 ( Figure 3) . Details of the fees charged by the remaining 2 journals (9%) are not available from their websites because the details are only provided when the article is accepted. 
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